Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

GP-3269 on track for clinical testing

May 17, 1996

SB-204269 in phase I for epilepsy

May 17, 1996

Ketoconazole: Potential treatment for depression?

May 17, 1996

Scios to copromote venlafaxine with Wyeth-Ayerst

May 17, 1996

5-HT1D antagonists disclosed by SmithKline Beecham

May 17, 1996

Pfizer claims 5-HT1 agonists and antagonists for CNS disorders

May 17, 1996

Sertindole clinical trial results reported at APA meeting

May 17, 1996

NIH scientists report ligands for alpha5-containing GABA-A receptors

May 17, 1996

Paroxetine approved for new indication

May 17, 1996

Kappa-opioid agonists reported by Pfizer

May 17, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 27, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...